Q4 2025 EARNINGS March 12, 2026 Q4 EARNINGS | 2025 1 Presentation Disclosures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding our product offerings, our strategic plan and speed to market, future financial results, including without limitation, full-year ...

SHIMMICK CORPORATION Q4 2025 Earnings Presentation March 12, 2026 Disclaimer This presentation is being delivered on behalf of Shimmick Corporation (the "Company"). The sole purpose of this presentation is to provide information in connection with a review of the Company's operations and/or financial status. This presentation does not purport to be all-inclusive or to contain all of the information that prospective investors may desire in reviewing the Company. 2 Shimmick Overview Shimmick is a leading cont ...

Total Heart Intelligence… Wherever You Are FOURTH QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL MARCH 12, 2026 NASDAQ: BEAT Disclaimer The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. Also, these forward-looking statements represent the Company's estimates and assumptions only as of the date of this presentation. The Comp ...

Fourth Quarter & Full Year 2025 Financial Results March 2026 Pipeline Update Jacqueline Shea, PhD, President & Chief Executive Officer Financial Results Peter Kies, Chief Financial Officer CEO Perspective & Corporate Progress Jacqueline Shea, PhD, President & Chief Executive Officer INO-3107 Update Michael Sumner, MBBS, MBA, Chief Medical Officer Steve Egge, MBA, Chief Commercial Officer Agenda Introduction Jennie Willson, Director, Communications Forward-Looking Statements This presentation includes statem ...

KORU Medical Systems Q4 & FY 2025 Earnings Call March 12, 2026 1 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. All statements that are not historical fact are forward-looking statements. Forward-looking statements discuss the Company's current expectations and projections relating to its financial position, results of operations, plans, objectives, future perfor ...

Q4 & FY2026 Earnings Presentation March 12, 2026 Safe Harbor This presentation includes express and implied "forward-looking statements", including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts, and in some cases, can be identified by terms such as "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "pre ...

Summary of ASP Isotopes FY Conference Call Company Overview - **Company**: ASP Isotopes (NasdaqCM:ASPI) - **CEO**: Paul Mann - **Date of Conference**: March 12, 2026 Industry Context - **Helium Shortage**: A significant helium shortage is impacting semiconductor production and other industries, with 25%-30% of the world's helium supply currently offline due to production issues in Qatar [3][5][6]. - **Production Rates**: Current helium production is at approximately 4.5 billion cubic feet (BCF) annually, while demand is around 6.5 BCF, indicating a supply-demand gap [5]. Key Points on Helium Supply - **Geopolitical Factors**: The closure of the Strait of Hormuz and damage to Qatar's LNG facility have exacerbated the helium supply crisis [6]. - **ASP Isotopes' Role**: ASP Isotopes owns Renergen, which is expected to be one of the largest helium producers by the end of the decade. The company is currently in phase one of its helium liquefied natural gas plant build-out [6][7]. - **Production Capacity**: Phase one is projected to produce about 58 thousand cubic feet (MCF) of helium per day, with potential revenues of $8 million annually at current helium prices [10][12]. Financial Projections - **Revenue Estimates**: Combined annualized revenue from helium and LNG is estimated at $20 million, with gross profits around $5 million. Higher helium prices could significantly increase profits [10][11][12]. - **Government Support**: The U.S. government has deemed ASP's helium facilities critical, committing $500 million to phase two of the project [11][12]. Isotope Production Updates - **Silicon-28**: Initial samples shipped in August 2025 have been confirmed for quality. The plant is set to restart soon after implementing safety and efficiency improvements [21][23]. - **Carbon-14**: Feedstock from Canada is expected imminently, with production anticipated to start within 60-90 days [24][25]. - **Ytterbium-176**: Production is currently limited due to a laser failure, but operations are expected to ramp up to commercial volumes soon [28][29]. Regulatory and Strategic Developments - **Regulatory Advancements**: ASP has signed a service level agreement with the South African Nuclear Energy Corporation, allowing for uranium enrichment at an existing facility [34][35]. - **Partnerships**: Collaboration with TerraPower for uranium enrichment is ongoing, with a focus on meeting timelines for reactor fuel supply [38]. Strategic Vision - **Integration of Operations**: The acquisition of Renergen is seen as a strategic move to create a comprehensive electronic gases company, integrating helium production with semiconductor and medical isotope operations [40][41][42]. - **Future Growth**: ASP Isotopes aims to become a low-cost producer of isotopes by exploring locations with cheap energy for new plants, including Iceland and North America [52][53]. Conclusion - ASP Isotopes is positioned to play a critical role in addressing the helium supply crisis while expanding its isotope production capabilities. The company's strategic acquisitions and partnerships are aimed at enhancing its market position in the semiconductor and medical isotope sectors.

Cadrenal Therapeutics (NasdaqCM:CVKD) Conference March 12, 2026 03:00 PM ET Company ParticipantsQuang Pham - Chairman and CEONone - Company RepresentativeConference Call ParticipantsDavid Bautz - Senior Equity AnalystNoneHello, and welcome to the Life Science Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next presentation of the day is from Cadrenal Therapeutics. Their session will be moderated by David Bautz, Senior Equity An ...

Financial Performance - In Q4 2025, gross profits more than doubled quarter-over-quarter, rising to $17.4 million from $7.8 million in Q3 2025 [12] - For the full year, gross profit increased to $47.6 million, up from $30.9 million in 2024 [12] - Q4 2025 net income was $38.1 million or $0.70 per share, compared to a net loss of $8.2 million or $0.16 per share in Q4 2024 [12] - Full year net income was $34.4 million, a turnaround from a net loss of $43.7 million in 2024 [13] - The company ended the year with a strong cash position of $51 million compared to $14 million at the end of 2024 [14] Business Lines Performance - The San José Mine reported $33.5 million in Q4 2025 for the company's 49% interest, contributing significantly to the overall performance [13] - The company is focusing on projects like Gray Fox and Gold Bar, which are expected to generate cash flow and support growth [8][9] Market and Industry Trends - The company is optimistic about the copper market, with prices around $5.80 per pound, and forecasts from major banks suggest prices will remain elevated [31] - There is a structural deficit forecasted for copper supply, driven by increased demand from AI data centers, electrification of transport, and renewable energy investments [32] Company Strategy and Development Direction - The company aims to double its precious metal production by 2030 through exploration and acquisitions [3] - McEwen Copper's Los Azules project is positioned as a low-impact, environmentally sensitive operation, with plans for a public listing later in 2026 [4][30] - The company is actively pursuing M&A opportunities, focusing on properties adjacent to existing operations to extend mine life and production [48][96] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to finance growth without excessive dilution of shareholder value, primarily through internal cash flow [6][9] - The management highlighted the importance of maintaining a strong balance sheet and operational discipline to support future growth [14] Other Important Information - The company is working on a pre-feasibility study for the Gray Fox project, expected to be released in June 2026 [18] - The Los Azules project has secured regulatory stability through RIGI approval, which is expected to attract significant investment [23][24] Q&A Session Summary Question: Will Stock contribute to 2026 guidance? - Management confirmed that production from Stock is expected in the second half of 2026, but it is not included in the current guidance [46][47] Question: What is the strategy for M&A? - The company is focusing on acquiring properties near existing operations to enhance production without spreading resources too thin [48][96] Question: Update on McEwen's stake in Paragon? - The company holds approximately 28% in Paragon, which is gaining acceptance in the industry for its photon assay technology [102][103]

Financial Data and Key Metrics Changes - In Q4 2025, gross profits more than doubled quarter-over-quarter, rising to $17.4 million from $7.8 million in Q3 2025 [11] - For the full year, gross profit increased to $47.6 million, up from $30.9 million in 2024 [11] - Q4 2025 net income was $38.1 million or $0.70 per share, compared to a net loss of $8.2 million or $0.16 per share in Q4 2024 [11] - Full year net income was $34.4 million, a turnaround from a net loss of $43.7 million in 2024 [12] - The company ended the year with a strong cash position of $51 million compared to $14 million at the end of 2024 [13] Business Line Data and Key Metrics Changes - The San José Mine contributed $33.5 million in Q4 2025 for the company's 49% interest [12] - The company is focusing on expanding existing operations and several acquisitions to double precious metal production by 2030 [2][3] Market Data and Key Metrics Changes - The company realized over $4,400 per ounce of gold in Q4 2025, benefiting from higher gold prices [12] - Copper prices are currently around $5.80 per pound, with forecasts indicating continued strength in the market [28] Company Strategy and Development Direction - The company aims to take McEwen Copper public later in 2026, leveraging the strong economics of the Los Azules copper project [3][26] - The focus is on environmentally sensitive mining practices, with plans for the Los Azules project to utilize 100% renewable energy and have no tailings [3][25] - The company is actively pursuing M&A opportunities, particularly in junior mining companies that can complement existing operations [33] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing a favorable environment for copper and precious metals driven by electrification and AI infrastructure [28][30] - The company is preparing for a multi-year super cycle in copper, with structural deficits expected in supply [29][30] Other Important Information - The company received a dividend of $8.8 million from the San José Mine in February 2026 [13] - The feasibility study for the Los Azules project indicates a strong after-tax NPV of $2.9 billion at a base case copper price of $4.35 per pound [22] Q&A Session Summary Question: Information on the IPO for McEwen Copper - The company is looking to complete several tasks before proceeding with the IPO later this year [33] Question: Current attributable silver production - The company currently produces approximately 3.6 million ounces of silver from the San José mine, with plans for future production from El Gallo phase two [34] Question: Production guidance for Stock Mine - Production from Stock is expected to ramp up in the second half of the year, with pre-commercial production analysis to be reported [42][51] Question: M&A strategy and opportunities - The company is focused on acquiring properties adjacent to existing operations to extend mine life and increase production [44][92] Question: Update on McEwen's stake in Paragon - The company holds about 28% in Paragon, which is gaining acceptance in the industry for its photon assay technology [96][98]